![](/images/general/no_picture/200_user.png)
Hai V Tran
Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )
Most Active Art Unit | 2845 |
Art Unit(s) | 2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821 |
Total Applications | 1291 |
Issued Applications | 923 |
Pending Applications | 111 |
Abandoned Applications | 257 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17748223
[patent_doc_number] => 20220226426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => OPHTHALMIC COMPOSITION FOR THE TREATMENT OF OCULAR ALLERGY
[patent_app_type] => utility
[patent_app_number] => 17/613832
[patent_app_country] => US
[patent_app_date] => 2020-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613832
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/613832 | OPHTHALMIC COMPOSITION FOR THE TREATMENT OF OCULAR ALLERGY | May 22, 2020 | Pending |
Array
(
[id] => 16628712
[patent_doc_number] => 20210047365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => METHODS AND SYSTEMS FOR SOLID PHASE PEPTIDE SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 16/874824
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874824 | Methods and systems for solid phase peptide synthesis | May 14, 2020 | Issued |
Array
(
[id] => 16389607
[patent_doc_number] => 20200330548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS
[patent_app_type] => utility
[patent_app_number] => 16/874218
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874218
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874218 | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS | May 13, 2020 | Abandoned |
Array
(
[id] => 16598052
[patent_doc_number] => 20210024583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => COMPOSITIONS AND METHODS FOR PEPTIDE MEDIATED OLIGONUCLEOTIDE DELIVERY TO THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/931182
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931182
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931182 | COMPOSITIONS AND METHODS FOR PEPTIDE MEDIATED OLIGONUCLEOTIDE DELIVERY TO THE CENTRAL NERVOUS SYSTEM | May 12, 2020 | Abandoned |
Array
(
[id] => 16555760
[patent_doc_number] => 20210000908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => HMGB1 ANTAGONIST TREATMENT OF SEVERE SEPSIS
[patent_app_type] => utility
[patent_app_number] => 16/869905
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869905 | HMGB1 antagonist treatment of severe sepsis | May 7, 2020 | Issued |
Array
(
[id] => 16359413
[patent_doc_number] => 20200316164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => FORMULATIONS AND METHODS FOR TREATING ULCERATIVE COLITIS
[patent_app_type] => utility
[patent_app_number] => 16/853352
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853352
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853352 | FORMULATIONS AND METHODS FOR TREATING ULCERATIVE COLITIS | Apr 19, 2020 | Abandoned |
Array
(
[id] => 17911430
[patent_doc_number] => 20220313825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/594454
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594454 | PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES | Apr 15, 2020 | Pending |
Array
(
[id] => 18171712
[patent_doc_number] => 11571404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
[patent_app_type] => utility
[patent_app_number] => 16/848952
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 28592
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848952
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848952 | Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting | Apr 14, 2020 | Issued |
Array
(
[id] => 17349947
[patent_doc_number] => 11224565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => N-acyldipeptide derivatives and their uses
[patent_app_type] => utility
[patent_app_number] => 16/845513
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18005
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845513
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/845513 | N-acyldipeptide derivatives and their uses | Apr 9, 2020 | Issued |
Array
(
[id] => 16628716
[patent_doc_number] => 20210047369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => METHODS FOR REDUCING CD36 EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 16/838290
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16838290
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/838290 | Methods for reducing CD36 expression | Apr 1, 2020 | Issued |
Array
(
[id] => 16451101
[patent_doc_number] => 20200360527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => Molecular-Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Intrarenal Deposition and Bioavailability
[patent_app_type] => utility
[patent_app_number] => 16/834715
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/834715 | Molecular-size of elastin-like polypeptide delivery system for therapeutics modulates intrarenal deposition and bioavailability | Mar 29, 2020 | Issued |
Array
(
[id] => 18056523
[patent_doc_number] => 20220387609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => BRANCHED DEGRADABLE POLYETHYLENE GLYCOL BINDER
[patent_app_type] => utility
[patent_app_number] => 17/599402
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599402 | BRANCHED DEGRADABLE POLYETHYLENE GLYCOL BINDER | Mar 25, 2020 | Pending |
Array
(
[id] => 16175533
[patent_doc_number] => 20200222501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/829539
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16829539
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/829539 | PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION | Mar 24, 2020 | Abandoned |
Array
(
[id] => 17677065
[patent_doc_number] => 20220190232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => PIEZOELECTRIC PEPTIDE-BASED MATERIALS AND PIEZOELECTRIC DEVICES CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/442765
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/442765 | PIEZOELECTRIC PEPTIDE-BASED MATERIALS AND PIEZOELECTRIC DEVICES CONTAINING SAME | Mar 24, 2020 | Pending |
Array
(
[id] => 16310921
[patent_doc_number] => 20200289659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => CONJUGATES FOR TREATING DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/825566
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825566
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/825566 | CONJUGATES FOR TREATING DISEASES | Mar 19, 2020 | Abandoned |
Array
(
[id] => 16296266
[patent_doc_number] => 20200281989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => METHOD OF PREPARING A COMPOSITION FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/809385
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/809385 | METHOD OF PREPARING A COMPOSITION FOR TREATING CANCER | Mar 3, 2020 | Abandoned |
Array
(
[id] => 16090391
[patent_doc_number] => 20200199182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => MODIFIED LANTIBIOTICS AND METHODS OF MAKING AND USING THE MODIFIED LANTIBIOTICS
[patent_app_type] => utility
[patent_app_number] => 16/806641
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806641
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/806641 | Modified lantibiotics and methods of making and using the modified lantibiotics | Mar 1, 2020 | Issued |
Array
(
[id] => 17702914
[patent_doc_number] => 20220202920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHOD FOR TREATING PREECLAMPSIA
[patent_app_type] => utility
[patent_app_number] => 17/429887
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429887
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429887 | METHOD FOR TREATING PREECLAMPSIA | Feb 9, 2020 | Pending |
Array
(
[id] => 17480645
[patent_doc_number] => 20220088149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => Liquid Pharmaceutical Formulations of PTH Conjugates
[patent_app_type] => utility
[patent_app_number] => 17/428608
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428608
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428608 | Liquid Pharmaceutical Formulations of PTH Conjugates | Feb 9, 2020 | Pending |
Array
(
[id] => 17546712
[patent_doc_number] => 20220118053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => Dry Pharmaceutical Formulations of CNP Conjugates
[patent_app_type] => utility
[patent_app_number] => 17/428604
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428604
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428604 | Dry Pharmaceutical Formulations of CNP Conjugates | Feb 9, 2020 | Pending |